![Tyle M. Dylan-Hyde](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tyle M. Dylan-Hyde
Plus aucun poste en cours
Profil
Tyle M.
Dylan-Hyde was the founder of Taxus Cardium Pharmaceuticals Group, Inc. founded in 2003, where he held the titles of Secretary, Director, General Counsel & EVP.
He also held former positions as Secretary, Director, Chief Business Officer & EVP at Tissue Repair Co. from 2006 to 2014, Director & Chief Business Officer at To Go Brands, Inc. from 2012 to 2013, Secretary, Chief Business Officer & EVP at Aries Ventures, Inc. from 2005 to 2006, Vice President & General Counsel at Collateral Therapeutics, Inc. from 1998 to 2002, Partner at Morrison & Foerster LLP, and Secretary, Chief Business Officer & EVP at Post-Hypothermia Corp.
from 2006 to 2009.
He also served as Chief Legal Officer at CRISPR Therapeutics AG from 2015 to 2018.
Dr. Dylan-Hyde's education includes an undergraduate degree from McGill University, a graduate degree from the University of California, Berkeley, and a doctorate degree from the University of California San Diego.
Anciens postes connus de Tyle M. Dylan-Hyde
| Sociétés | Poste | Fin |
|---|---|---|
| CRISPR THERAPEUTICS AG | Conseiller Juridique Général | 26/03/2018 |
Tissue Repair Co.
 Tissue Repair Co. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops wound healing products for chronic wounds and aftercare | Directeur/Membre du Conseil | 01/11/2014 |
To Go Brands, Inc.
 To Go Brands, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets health products | Directeur/Membre du Conseil | 01/11/2013 |
Post-Hypothermia Corp.
 Post-Hypothermia Corp. Medical SpecialtiesHealth Technology Manufactures and markets temperature modulation therapy devices | Conseiller Juridique Général | 01/07/2009 |
Aries Ventures, Inc.
 Aries Ventures, Inc. Financial ConglomeratesFinance Financial investment vehicle | Conseiller Juridique Général | 23/01/2006 |
Formation de Tyle M. Dylan-Hyde
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
31
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Aries Ventures, Inc.
Aries Ventures, Inc. Financial ConglomeratesFinance Financial investment vehicle | Finance |
Collateral Therapeutics, Inc.
 Collateral Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers, develops and commercializes non-surgical gene therapy products | Commercial Services |
Tissue Repair Co.
Tissue Repair Co. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops wound healing products for chronic wounds and aftercare | Health Technology |
Morrison & Foerster LLP
 Morrison & Foerster LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Post-Hypothermia Corp.
Post-Hypothermia Corp. Medical SpecialtiesHealth Technology Manufactures and markets temperature modulation therapy devices | Health Technology |
Taxus Cardium Pharmaceuticals Group, Inc.
 Taxus Cardium Pharmaceuticals Group, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes angiogenic gene therapy products for cardiovascular disease | Health Technology |
To Go Brands, Inc.
To Go Brands, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets health products | Health Technology |
CRISPR Therapeutics AG
 CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
